Sign in

CIK 0001196298

  • Non-accelerated filer
  • Smaller reporting company

NEPHROS INC

Sign in to watch
Ticker
NEPH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133971809
Phone
+1 201-343-5202
Business address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
  1. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.26 ($5,198)
  2. 4 Open-market buy President and CEO bought 21,461 shares at $0.26 ($5,580)
  3. 4 Open-market buy President and CEO bought 30,000 shares at $0.26 ($7,650)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award President and CEO acquired 17,756 shares (grant or award)
  7. 4 Open-market buy Chief Financial Officer bought 166,666 shares
  8. 4 Open-market buy President and CEO bought 83,332 shares
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award President and CEO acquired 213,068 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 9,165 shares (grant or award)
  13. 4 Open-market buy President and CEO bought 4,069 shares at $0.32 ($1,302)
  14. 4 Open-market buy President and CEO bought 10,620 shares at an average $0.34 ($3,610)
  15. 4 Open-market buy President and CEO bought 41,530 shares at an average $0.32 ($13,286)
  16. 4 Grant or award Director acquired 73,864 shares (grant or award)
  17. 4 Grant or award Director acquired 113,636 shares (grant or award)
  18. 4 Grant or award Director acquired 73,864 shares (grant or award)
  19. 4 Grant or award Director acquired 73,864 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 8 of 17 · 332 filings